Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

A monthly toric contact lens can allow digital device users to experience all-day comfort, even with more than 8 hours of wear.

Choroidal vascularity index can reveal treatment response and disease activity among patients with chronic CSCR undergoing PDT treatment.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure.

People still see COVID-19 as an ongoing public health threat, even though the pandemic officially ended in 2023.

A slew of recalled OTC eye drops during the past 2 years has diminished patient trust, but optometrists are equipped to restore it.

Fasting plasma glucose (FPG), age, body mass index (BMI), and male sex are all associated with development of diabetes.

Topline results were announced from a phase 2/3 trial evaluating linsitinib for the treatment of moderate to severe thyroid eye disease.

Volumetric myopia defocus dosage may be useful for predicting long-term axial growth in patients undergoing ortho-k.

Historical redlining is linked to care utilization and fragmentation among patients with rheumatic conditions, highlighting the role of structural racism in these disparities.

HDL cholesterol levels demonstrate a U-shaped association with AMD, in which both high and low levels elevate risk.